# Trade Mark Journal No.2026/027 3 July 2026

## UK00004406264 23 June 2026 (40,42)

INAAVATE

Class 40
  Custom manufacture of products relating to biotechnology; manufacture of gene and cell-based therapy products, viral vectors, retroviral vectors, lentiviral vectors, adeno-associated viral vectors, adenoviral vectors, and non-vector preparations and biopharmaceutical products; biotechnology contract manufacturing services; contract manufacturing services of gene and cell-based therapy products, viral vectors, retroviral vectors, lentiviral vectors, adeno-associated viral vectors, adenoviral vectors, and non-vector preparations and biopharmaceutical products; contract manufacturing services of technology for biopharmaceutical products and gene and cell-based products; contract manufacturing services of technology for viral vectors, retroviral vectors, lentiviral vectors, adeno-associated viral vectors, adenoviral vectors, and non-vector preparations.
Class 42
  Research and laboratory analytic and diagnostic services; design of manufacturing facilities; quality control and validation services; product development consultancy in the field of nanotechnology, gene therapy and vector-based delivery systems; product, viral vector and analytic assay development for others; laboratory services; research and development services; genetic engineering laboratories and biochemistry laboratories; scientific and technological services and research; industrial analysis services; provision of information relating to scientific research; provision of scientific information; research and scientific analysis relating to drug discovery and development for others; scientific advisory services; scientific consultancy; scientific research and development; scientific research in the field of biotechnology and pharmaceuticals; management of scientific research projects; issuing of scientific information; advisory services relating to scientific and clinical research; biological research, clinical research and medical research; conducting clinical trials; manufacturing development services; contract research and development services.

Oxford BioMedica plc

Representative: Kilburn & Strode LLP